webinar register page

PRCHN February 2021 Seminar: Addressing barriers to tobacco treatment for people with comorbid conditions in the healthcare setting
Patients diagnosed with comorbid physical and mental health conditions who smoke need to quit smoking for the benefit of both their comorbid condition outcomes and their long-term health. Yet, systemic barriers prevent many patients who present for medical treatment from getting the evidence-based tobacco treatment that they need. This presentation will discuss barriers and potential solutions to increasing the availability of successful, evidence-based tobacco treatment programs in healthcare systems. Areas of potential future research will be discussed.

Feb 10, 2021 12:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Alana Rojewski, PhD
Asst Professor of Public Health Sciences, Associate Director, Tobacco Treatment Program, Medical University of South Carolina
Dr. Alana Rojewski is an Assistant Professor in the Department of Public Health Sciences at the Medical University of South Carolina and an Associate Research Member of Hollings Cancer Center. She is also a Tobacco Treatment Specialist and the Associate Director of the MUSC Health Tobacco Treatment Program. Dr. Rojewski’s program of research is focused on the development of tobacco treatment interventions for people with comorbid conditions, and the implementation of tobacco treatment interventions in the healthcare setting. Dr. Rojewski was awarded an NCI K07 in 2017 to investigate a gain-framed text messaging intervention that is tailored to lung cancer screening patients. She also serves as a Co-Investigator on several NCI-funded R01s. Dr. Rojewski received her degree from the University of Florida and completed a NIDA postdoctoral fellowship at Yale School of Medicine.